EP
EPITHELIX SARL
Grant-FundedCORDISDeveloping broad-spectrum antiviral drugs for pandemic preparedness
Biotech
EPITHELIX SARL is a private SME recorded in CORDIS in Switzerland, with participation in 6 EU research and innovation projects. Its recorded projects include “Developing broad-spectrum antiviral drugs for pandemic preparedness”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€902,506
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇨🇭Switzerland
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
EPITHELIX SARL is a private SME recorded in CORDIS in Switzerland, with participation in 6 EU research and innovation projects. Its recorded projects include “Developing broad-spectrum antiviral drugs for pandemic preparedness”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Biotech
Tags:Biotech
Company Info
EPITHELIX SARL Info
Funding
EU Grants€902,506